Hyperthermia after cardiac surgery

Canadian Journal of Anaesthesia

Volumn 44, Issue 6, 1997, Pages 662-665

  Abe, Kazuo ^a   Miyamoto, Yuji ^b   Ohnishi, Kenji ^b  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b Sakurabashi Watanabe Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; CATECHOLAMINE; CREATINE KINASE; DANTROLENE; DIAZEPAM; FENTANYL; HYDROXYZINE; METHYLPREDNISOLONE; MYOGLOBIN; PANCURONIUM; PROTAMINE; TRYPTASE; VECURONIUM;

ADULT; AGED; ANAPHYLAXIS; ARTERIAL GAS; ARTICLE; CASE REPORT; CORONARY ARTERY DISEASE; HEART SURGERY; HUMAN; HYPERCAPNIA; HYPERTHERMIA; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; HYPOTENSION; HYPOXIA; MALE; MALIGNANT HYPERTHERMIA; METABOLIC ACIDOSIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RECTUM TEMPERATURE; THORACIC AORTA ANEURYSM;

EID: 0030794712     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03015452     Document Type: Article

References (12)

1. Takenoshita M, Sugiyama M, Okuno Y, Inagaki Y, Yoshiya I, Shimazaki Y. Anaphylactoid reaction to protamine confirmed by plasma tryptase in a diabetic patient during open heart surgery. Anesthesiology 1996; 84: 233-5.
2. Levy JH, Zaidan JR, Faraj B. Prospective evaluation of risk of protamine reactions in patients with NPH insulin-dependent diabetics. Anesth Analg 1986; 65: 739-42.
3. Stewart WJ, McSweeney SM, Kellett MA, Faxon DP, Ryan TJ. Increased risk of severe protamine reactions in NPH insulin-dependent diabetics undergoing cardiac catheterization. Circulation 1984; 70: 788-92.
4. Schwartz LB, Yunginger JW, Miller J, Bokhari R, Dull D. Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis. J Clin Invest 1989; 83: 1551-5.
5. Laroche D, Vergnaud M-C, Sillard B, Soufarapis H, Bricard H. Biochemical markers of anaphylactoid reactions to drugs. Anesthesiology 1991; 75: 945-9.
6. Britt BA. Recent advances in malignant hyperthermia. Anesth Analg 1972; 51: 841-50.
7. Gronert GA. Malignant hyperthermia Anesthesiology 1980; 53: 395-423.
8. Ducart A, Adnet P, Renaud B, Riou B, Krivosic-Horber R. Malignant hyperthermia during sevoflurane administration Anesth Analg 1995; 80: 609-11.
9. Ochiai R, Toyoda Y, Nishio I, et al. Possible association of malignant hyperthermia with sevoflurane anesthesia. Anesth Analg 1992; 74: 616-8.
10. Allen GC, Cattran CB. Rewarming following hypothermie cardiopulmonary bypass in the malignant hyperthermia-susceptible patient: implications for diagnosis and perioperative management Can J Anaesth 1989; 36: 81-5.
11. Sladen RN. Temperature and ventilation after hypothermie cardiopulmonary bypass. Anesth Analg 1985; 64: 816-20.
12. Kolb ME, Horne ML, Martz R. Dantrolene in human malignant hyperthermia. Anesthesiology 1982; 56: 254-62.